ACOR News and Press, Acorda Therapeutics Inc. From 05/07/21

The following slide deck was published by Acorda Therapeutics, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Acorda Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

Acorda Therapeutics (ACOR): Q1 Non-GAAP EPS of -$2.46 beats by $0.08; GAAP EPS of -$3.53 beats by $0.18.Revenue of $28.86M (+2.7% Y/Y) beats by $6.71M.Press Release For further details see: Acorda Therapeutics EPS beats by $0.08, beats on revenue

INBRIJA ® (levodopa inhalation powder) Q1 2021 net revenue of $5 million; 13% increase over Q1 2020 INBRIJA organic growth (dispensed cartons) was 25% Q1 2021 over Q1 2020 AMPYRA ® (dalfampridine) Extended Release Tablets, 10 mg Q1 2021 net revenue of $2...

#Investors in Acorda Therapeutics (NASDAQ: ACOR) like to make good #decisions, that means they like to #buyandsell at the right times, and to do that the best tools involve charts, pivot points, and the technical data.  Below, we have provided a snapshot for ACOR that ...

Acorda Therapeutics appears to be making moves to prepare for a potential turnaround in the coming years. I intend to discuss the company's prospects for a turnaround. The company sold some of their manufacturing operations which provided some cash and decreased INBRIJA's cost of good...

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2021 update and financial results on Thursday, May 6 at 4:30 p.m. ET. To participate in the Webcast/Conference Call, please note there is a new pre-registration pro...

Gainers: Aesthetic Medical International (AIH) +14%, Acorda Therapeutics (ACOR) +13%, Outlook Therapeutics (OTLK) +12%, Organovo (ONVO) +12%, Asensus Surgical (ASXC) +11%.Losers: Atea Pharmaceuticals (AVIR) -7%, Inotiv NOTV -7%, Lava Ther...

When influential investors make decisions to buy and sell securities, they normally want to keep it quiet.  However, if we pay close attention we can see what is going on, and make good decisions.. The Acorda Therapeutics (NASDAQ: ACOR) report below can help you understand how to d...

“ This is my party, but you are invited, ” says Chef Zarela Culinary icon Zarela Martinez and Acorda Therapeutics (NASDAQ: ACOR) have partnered to launch “A Taste for Life with Zarela” to celebrate Parkinson’s Awareness Month. T...

Investors often shrug off the impact of stimulus, but when fabricated demand comes into the stock market everything is affected, even Acorda Therapeutics (NASDAQ: ACOR) and other stocks that might not be direct beneficiaries.  They say, a rising tide lifts all boats, and multiple e...